Patent details
EP2788001 Title: NASAL FORMULATION
Basic Information
- Publication number:
- EP2788001
- PCT Application Number:
- PCT/EP/2012/074374
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP127978849
- PCT Publication Number:
- WO/2013/083569
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NASAL FORMULATION
- French Title of Invention:
- FORMULATION NASALE
- German Title of Invention:
- FORMULIERUNG ZUR NASALEN VERABREICHUNG
- SPC Number:
Dates
- Filing date:
- 04/12/2012
- Grant date:
- 02/12/2015
- EP Publication Date:
- 02/12/2015
- PCT Publication Date:
- 13/06/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/10/2014
- EP B1 Publication Date:
- 02/12/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 04/12/2015
- Expiration date:
- 04/12/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/12/2012
- Name:
- Teva Branded Pharmaceutical Products R & D Inc.
- Address:
- 41 Moores Road, Frazer, Pennsylvania 19355, United States (US)
Inventor
1
- Name:
- LY Jade Ching-Ying
- Address:
- United States (US)
2
- Name:
- DALVI Mukul C
- Address:
- United States (US)
3
- Name:
- ZENG Xian-Ming
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201161567893
- Priority Date:
- 07/12/2011
- Priority Country:
- United States (US)
2
- Priority Number:
- 201121812
- Priority Date:
- 19/12/2011
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/55;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|